Carotid Artery Plaque Vulnerability Assessment Using Ultrafast Ultrasound

Status Not yet recruiting

Clinical Trial Summary

Objective: To explore the association between spatio-temporal blood flow velocities (peak systole and end-diastole at prior-stenosis, at maximum stenosis, and post-stenosis) and carotid plaque vulnerability defined by histology staining. Secondary, to assess the association between ultrasound elastography and carotid plaque vulnerability defined by histology staining. Furthermore, to assess the association between blood flow-derived parameters, including wall shear stress (WSS), vector complexity and vorticity, and plaque vulnerability. To evaluate the hemodynamic consequences of a CEA. Last, to explore whether the presence of circulating biomarkers is related to the degree of plaque vulnerability (as reflected by histology and/or ultrasound). Study design: A multicentre, prospective, observational, cohort study in a total of 70 patients. Study population: Patients with a carotid artery stenosis ≥50% according to clinically performed imaging (i.e. duplex, computed tomography angiography (CTA), or magnetic resonance angiography (MRA)) that are scheduled for a CEA. Intervention (observational): A carotid ultrasound with flow and elastography (strain and shear wave) measurements will be performed maximally 2 weeks prior to the CEA. In the first 20 included patients in the Radboudumc, a 10 mL blood sample will be collected during surgery via the arterial line that is applied for regular care. The plaque excised during CEA will be histologically examined to assess the plaque composition, and therefore plaque vulnerability. Ultrasound-based flow imaging will be repeated six weeks after the CEA to assess the hemodynamic consequences of the CEA procedure. Besides, clinical parameters will be subtracted from electronic health record or, if missing, anamnestically collected from the patient. Main study parameters/endpoints: Association between 2D spatio-temporal blood flow velocities (peak systole and end-diastole at prior-stenosis, maximum stenosis and post-stenosis), measured by ultrafast ultrasound measurements, and plaque vulnerability (stable versus unstable), defined by histology staining.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05218421
Study type	Observational
Source	Radboud University Medical Center
Contact
Status	Not yet recruiting
Phase
Start date	February 1, 2022
Completion date	November 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02224339` - New Technologies to Determine Carotid Plaque Vulnerability
Recruiting	`NCT05549336` - Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
Recruiting	`NCT05123287` - A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
Recruiting	`NCT04679727` - The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
Recruiting	`NCT02476396` - Structural Stability of Carotid Plaque and Symptomatology
Completed	`NCT02947360` - The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER	N/A
Completed	`NCT03335033` - New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques	Phase 2
Recruiting	`NCT05029661` - Ultrasound Elastography for Individual Carotid Plaque Stratification
Not yet recruiting	`NCT05622877` - The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque	Phase 1
Not yet recruiting	`NCT03072225` - Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine	Phase 2
Recruiting	`NCT04073797` - PET Imaging of Inflammation and Lipid Lowering Study	N/A
Recruiting	`NCT04470687` - Ultrafast Ultrasound Imaging Assesment of Carotid Plaque Neovascularization	N/A
Completed	`NCT05566080` - Preoperative Identification of the Histologically "Vulnerable" Plaque Using Non-invasive Imaging, Biomechanical Assessment and Baroreflex Evaluation in Patients With Severe Carotid Stenosis
Active, not recruiting	`NCT04913493` - Use of Sublingual Microcirculation and FloTrac Monitoring During Major Vascular Surgery and Its Effect on Hospital LOS	N/A
Completed	`NCT03982420` - The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
Completed	`NCT05134493` - Embolic Signals Detection Study (Esds) in Candidates for Surgical Carotid Revascularisation
Terminated	`NCT02667457` - 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis	Phase 2
Recruiting	`NCT04063709` - Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk	N/A
Completed	`NCT04318171` - The Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology
Completed	`NCT04835571` - CARotid Mri of Atherosclerosis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Carotid Artery Plaque Vulnerability Assessment Using Ultrafast Ultrasound Techniques — CAP-VALUE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms